4,506
Views
22
CrossRef citations to date
0
Altmetric
Mini Review

Immunotherapies and immunomodulatory approaches in clinical trials - a mini review

ORCID Icon, , , , , , , , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1897-1909 | Received 05 Oct 2020, Accepted 28 Dec 2020, Published online: 12 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi & Abbas Al Mutair. (2022) COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Human Vaccines & Immunotherapeutics 18:5.
Read now
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu & Vasso Apostolopoulos. (2022) A Global Picture: Therapeutic Perspectives for COVID-19. Immunotherapy 14:5, pages 351-371.
Read now
Suresh Bindu, Satyabrata Dandapat, Rajendran Manikandan, Murali Dinesh, Anbazhagan Subbaiyan, Pashupathi Mani, Manish Dhawan, Ruchi Tiwari, Muhammad Bilal, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Abbas Al Mutair, Zainab Al Alawi, Saad Alhumaid & Kuldeep Dhama. (2022) Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory. Human Vaccines & Immunotherapeutics 18:1.
Read now

Articles from other publishers (19)

Jiacheng He, Siqi Wu, Wu Chen, Albert Kim, Wen Yang, Chuanyu Wang, Zhengyang Gu, Jialiang Shen, Siyuan Dai, Weiqiang Chen & Pengyu Chen. (2023) Calligraphy of Nanoplasmonic Bioink-Based Multiplex Immunosensor for Precision Immune Monitoring and Modulation. ACS Applied Materials & Interfaces 15:43, pages 50047-50057.
Crossref
Juthaporn Cowan, Ashley Amson, Anna Christofides & Zain Chagla. (2023) Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations. International Journal of Infectious Diseases 134, pages 228-238.
Crossref
М. І. Брух, О. Р. Левицька, І. Я. Городецька, О. М. Корнієнко & Б. П. Громовик. (2023) Immunomodulators as objects of the pharmaceutical market. Message I. Analysis of the nomenclature of immunostimulators. Farmatsevtychnyi zhurnal:4, pages 3-13.
Crossref
Marcos Nuévalos, Estéfani García-Ríos, Francisco J. Mancebo, Clara Martín-Martín & Pilar Pérez-Romero. (2023) Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease. Trends in Microbiology 31:5, pages 480-497.
Crossref
Daniela Ricci, Marilena Paola Etna, Martina Severa, Stefano Fiore, Fabiana Rizzo, Marco Iannetta, Massimo Andreoni, Stefano Balducci, Paola Stefanelli, Anna Teresa Palamara & Eliana Marina Coccia. (2023) Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model. International Immunopharmacology 117, pages 109996.
Crossref
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, Souad A. Almuthree, Roua A. Alsubki, Amal H. Alfaraj, Mutaib M. Mashraqi, Saleh A. Alshamrani, Wesam A. Abduljabbar, Ameen S. S. Alwashmi, Fatimah Al Ibrahim, Abdulmonem A. Alsaleh, Faryal Khamis, Jameela Alsalman, Manish Sharma & Talha Bin Emran. (2023) Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines 11:1, pages 101.
Crossref
Sónia Soares, Mélina Bornet, Clara Grosso, Maria João Ramalhosa, Irene Gouvinhas, Juliana Garcia, Francisca Rodrigues & Cristina Delerue-Matos. (2022) Honey as an Adjuvant in the Treatment of COVID-19 Infection: A Review. Applied Sciences 12:15, pages 7800.
Crossref
Munawaroh Fitriah & Jusak Nugraha. (2022) Immunogenicity Assessment on Clinical Trials of SARS-CoV-2 Vaccines. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 28:2, pages 202-208.
Crossref
Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, Ali Adili, Shadi Ghoreishizadeh, Hossein Saeedi, Lakshmi Thangavelu, Navid Shomali, Ramin Aslaminabad, Faroogh Marofi, Mina Tahavvori, Svetlana Danshina, Morteza Akbari & Gülinnaz Ercan. (2022) A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Communication and Signaling 20:1.
Crossref
Sanchita Kar, Popy Devnath, Talha B. Emran, Trina E. Tallei, Saikat Mitra & Kuldeep Dhama. (2022) Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges. Immunity, Inflammation and Disease 10:4.
Crossref
Chen Zhang, Lin Fang, Xueyan Wang, Sen Yuan, Wanjing Li, Weiping Tian, Jing Chen, Qi Zhang, Yuxin Zhang, Qing Zhang & Junnian Zheng. (2022) Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma. Molecular Therapy - Oncolytics 24, pages 14-25.
Crossref
Chiranjib Chakraborty, Manojit Bhattacharya & Ashish Ranjan Sharma. (2021) Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity. Reviews in Medical Virology 32:2.
Crossref
Goutham V. Ganesh & Ramkumar K. Mohanram. (2021) Metabolic reprogramming and immune regulation in viral diseases. Reviews in Medical Virology 32:2.
Crossref
Sasan Ghaffari, Hanif Kazerooni & Amir Salehi-Najafabadi. (2021) An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19. International Immunopharmacology 101, pages 108226.
Crossref
Vamika Karn, Shaista Ahmed, Lung-Wen Tsai, Rajni Dubey, Shreesh Ojha, Himanshu Singh, Mukesh Kumar, Piyush Gupta, Soumi Sadhu, Niraj Jha, Ashutosh Kumar, Soumya Pandit & Sanjay Kumar. (2021) Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 9:10, pages 1373.
Crossref
Céline Barlier, Diego Barriales, Alexey Samosyuk, Sascha Jung, Srikanth Ravichandran, Yulia A. Medvedeva, Juan Anguita & Antonio del Sol. (2021) A Catalogus Immune Muris of the mouse immune responses to diverse pathogens. Cell Death & Disease 12:9.
Crossref
AbdulRahman A. Saied, Asmaa A. Metwally, Norah Abdullah Bazekh Madkhali, Shafiul Haque & Kuldeep Dhama. (2021) Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review. Frontiers in Public Health 9.
Crossref
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed A. Garout, Ayman M. Al-Qaaneh, Anupam A Sule, Raghavendra Tirupathi, Abbas Al Mutair, Saad Alhumaid, Abdulkarim Hasan, Manish Dhawan, Ruchi Tiwari, Khan Sharun, Ranjan K. Mohapatra, Saikat Mitra, Talha Bin Emran, Muhammad Bilal, Rajendra Singh, Salem A. Alyami, Mohammad Ali Moni & Kuldeep Dhama. (2021) Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 10:5, pages 565.
Crossref
Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, Amjad Khan, Anupam A Sule, Raghavendra Tirupathi, Abbas Al Mutair, Saad Alhumaid, Awad Al-Omari, Manish Dhawan, Ruchi Tiwari, Khan Sharun, Ranjan K. Mohapatra, Saikat Mitra, Muhammad Bilal, Salem A. Alyami, Talha Bin Emran, Mohammad Ali Moni & Kuldeep Dhama. (2021) Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines 9:5, pages 436.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.